Janus Henderson Group
MPLT

Janus Henderson Group’s MapLight Therapeutics MPLT Stock Holding History

Janus Henderson Group’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
+54,752
New +$979K ﹤0.01% 1649

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group's MPLT Position: Q1 2026 in Review

Janus Henderson Group opened a new position in MapLight Therapeutics (MPLT) in Q1 2026: 54,752 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #1649 among its holdings.

81 funds tracked by Wall St. Rank hold MPLT as of Q1 2026.

  • Janus Henderson Group held 54,752 shares of MapLight Therapeutics worth $1.11M as of Q1 2026.
  • MapLight Therapeutics was a new Janus Henderson Group position in Q1 2026.
  • MapLight Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1649 holding.
  • 81 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.